| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 42.45M | 45.36M | 43.75M | 39.17M | 32.73M | 26.07M |
| Gross Profit | 31.29M | 34.56M | 35.20M | 30.81M | 22.52M | 20.41M |
| EBITDA | 19.89M | 24.32M | 21.99M | 18.83M | 14.03M | 10.47M |
| Net Income | 13.69M | 16.62M | 15.26M | 12.93M | 9.34M | 6.43M |
Balance Sheet | ||||||
| Total Assets | 75.91M | 75.27M | 63.10M | 52.78M | 42.63M | 35.67M |
| Cash, Cash Equivalents and Short-Term Investments | 32.47M | 34.40M | 29.85M | 24.74M | 20.25M | 13.17M |
| Total Debt | 4.00M | 3.31M | 2.80M | 3.16M | 4.03M | 4.81M |
| Total Liabilities | 15.33M | 15.66M | 14.59M | 15.90M | 15.90M | 15.46M |
| Stockholders Equity | 60.58M | 59.61M | 48.51M | 36.88M | 26.73M | 20.21M |
Cash Flow | ||||||
| Free Cash Flow | 7.37M | 12.81M | 9.70M | 8.32M | 10.73M | 8.53M |
| Operating Cash Flow | 7.85M | 13.23M | 11.21M | 9.75M | 12.34M | 9.80M |
| Investing Cash Flow | -2.26M | -2.28M | -1.51M | -1.43M | -1.61M | -1.27M |
| Financing Cash Flow | -4.33M | -6.40M | -4.54M | -3.76M | -3.76M | -3.61M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | £7.23B | 19.73 | 81.91% | 1.94% | 8.75% | 15.70% | |
70 Outperform | £357.44M | 26.12 | 29.90% | 1.19% | 0.72% | -3.71% | |
68 Neutral | £203.01M | 82.94 | 5.22% | 0.80% | 19.00% | -53.85% | |
67 Neutral | £134.64M | 14.71 | 8.80% | 1.68% | 3.82% | -18.43% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | £120.48M | 28.82 | 7.38% | 1.92% | -7.27% | -15.76% | |
55 Neutral | £439.45M | -5.94 | -14.39% | 1.73% | 0.82% | -997.08% |